• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    32.56 Up 0.79(2.49%) 4:00PM EDT
    Add to Portfolio
    Prev Close:31.77
    Open:32.09
    Bid:29.55 x 100
    Ask:32.50 x 100
    1y Target Est:44.33
    Beta:0.923915
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:31.40 - 32.59
    52wk Range:27.92 - 45.45
    Volume:839,318
    Avg Vol (3m):636,528
    Market Cap:1.40B
    P/E (ttm):134.55
    EPS (ttm):0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORUp 2.49%1.40B
    BIIBUp 4.00%71.54B

    Key Statistics

    Forward P/E (1 yr):35.78
    P/S (ttm):3.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.71
    Quarterly EPS Est (Sep-15) :0.15
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):1.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback